Xenon Pharmaceuticals Inc. · NASDAQ:XENE
Avoro Capital Advisors LLC reported a 6.26% stake in Xenon Pharmaceuticals Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Avoro Capital Advisors LLC reported a 6.26% stake in Xenon Pharmaceuticals Inc., 5,777,777 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 6.26%
- Shares
- 5,777,777
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avoro Capital Advisors LLC | 6.26% | 5,777,777 |
| Behzad Aghazadeh | 6.26% | 5,777,777 |